Adagio Therapeutics (ADGI) – All Earnings Related News
-
Adagio Therapeutics (ADGI) Reports Q1 Net Loss of $100.7M, Cash Position of $532.2M
-
Adagio Therapeutics (ADGI) Issues Update on ADG20 COVID-19 Antibody Program; Reports Q3 Results
Back to ADGI Stock Lookup